Target intelligence / Profile preview

Serum protein corona components (PC)

Target
PC
Molecular classification
Protein complex, Biomolecular interface, Adsorbed protein layer
01

Overview

Serum protein corona components refer to the complex and dynamic assembly of proteins, lipids, and other biomolecules that spontaneously adsorb onto the surface of nanoparticles upon exposure to biological fluids like blood or serum (Monopoli et al., 2012, Nature Nanotechnology). This phenomenon is characterized by a 'hard corona' of high-affinity, slowly exchanging proteins and a 'soft corona' of low-affinity, rapidly exchanging proteins (Walkey & Chan, 2012, Chemical Society Reviews). The corona effectively masks the nanoparticle's synthetic surface properties, providing it with a 'biological identity' that dictates its physiological fate, including biodistribution, toxicity, and cellular internalization (Corbo et al., 2016, Nanomedicine). While not a single therapeutic target, the corona is a critical factor in nanomedicine design, as specific components like opsonins can trigger immune clearance, while others like apolipoproteins can facilitate crossing the blood-brain barrier (Borgognoni et al., 2019, Nanoscale). Understanding and manipulating the corona is essential for improving the efficacy and safety of nanoparticle-based drug delivery systems.

Other names
Nanoparticle-protein coronaBiomolecular coronaHard coronaSoft coronaProtein adsorption layer
02

Mechanism of action

The protein corona defines the biological identity of nanoparticles; it interacts with cell surface receptors (e.g., scavenger receptors, LDL receptors) to mediate endocytosis or triggers the mononuclear phagocyte system for clearance.

03

Biological functions

OpsonizationCellular uptakeBiodistributionImmune recognitionClearanceSignal transduction
04

Disease associations

InflammationImmunogenicityToxicityCancer (nanomedicine delivery)Complement activation-related pseudoallergy (CARPA)
05

Safety considerations

Rapid systemic clearanceOff-target accumulation in liver and spleenAnaphylactic reactionsLoss of targeting ligand functionalityToxicity due to protein unfolding
06

Interacting drugs

Liposomal doxorubicin

4 more in the full profile.

07

Biomarkers

Apolipoprotein E (ApoE) levelsAlbumin concentrationComplement factor C3Immunoglobulin G (IgG) titers

Beyond the preview

Go deeper on Serum protein corona components (PC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serum protein corona components (PC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call